Markets Live chat transcript for the chat ending at 11:12 on 18 Oct 2010. Participants in this chat were: Neil Hume, FT Bryce Elder
NH
and welcome to Markets Live
NH
FT Alphaville’s daily markets chat
NH
and we are SNAFU again this morning
NH
Bryce is back from his hols
BE
Good morning everyone.
NH
refreshed from a couple of weeks in Canada
NH
good you have you back
NH
and a settled formation for ML
BE
Good to be back. Relatively.
NH
very important to maintain our ML shape
NH
not sure you missed much
NH
other than a concerted effort by the US authorities to devalue the dollar
NH
and start a massive currency war
BE
Not in comparison to the Autonomy profit warning anyway.
BE
Sorry to have missed that. Always enjoy those.
NH
and for the first time since the warning
NH
that was dressed up as good news
NH
biggest riser in the FTSE 100 at the moment
Autonomy Corp Plc (AU.:LSE): Last: 1,369, up 21 (+1.56%), High: 1,371, Low: 1,319, Volume: 937.53k
BE
Let me guess – bid spec? M$? Oracle?
NH
not yet. expecting to hear the Microsoft/Oracle £20 a share takeover rumour
NH
I reckon the rise is down to the fact that results are looming
NH
and traditionally with Autonomy
NH
the trading statement unsettles
NH
and the results reassure
NH
also of course a massive
BE
Well, it’s regularly the opposite way as well.
BE
“We’ll beat expections ….” but ……….
BE
And there’s also a big acquisition to get out of the way.
NH
I suppose Spurs won at the weekend. that might help the price too, no?
NH
I have a couple of pieces on the results
NH
should bring you up to speed
NH
Investors have been mulling over buying Autonomy shares. The shares have
been pummelled, most recently by a half-hearted attempted patricide, so by
now one might be forgiven for thinking that the drama is played out. We
remind investors that Autonomy’s share price typically falls on results day, as
the detail irks. In addition to the pesky detail, Autonomy also has that
acquisition to announce. While, in our view, the acquisition should be
earnings enhancing, reviewing the reaction to previous enhancing deals
(Interwoven and Zantaz) shows that the shares need a couple of days to digest
the news. In our due diligence last week, being concerned about Autonomy’s
“volatility” comment, we attended an industry forum on Web Content
Management and heard 15-19% CAGR growth forecast by Gartner analysts. We
also tracked down the latest end-user research from Fulbright & Jaworski.
Both suggest strengthening Promote and Protect markets. So, while
Autonomy guidance looks cautious, the risk is that the results and acquisition
will put the shares under pressure, so we retain our Hold.
NH
Not much required to create a bounce…
Given the sharp correction in the share price since the preannouncement on 6 October we think Autonomy doesn’t need to do much to see a bounce: If it posts an unremarkable split of revenues (OEM up c30% y/y; Deferred Income flat-to-up sequentially; Cloud flat-to-down sequentially), and the balance sheet shows no stress beyond normal seasonality, the shares could easily move higher, in our view.
NH
…but a “show-me” stock for Q4
Nonetheless, Q4 guidance implies further deceleration to 6-7% organic growth y/y. If mgt can successfully convey that this is cautious (implying just a 14% q/q rise in sales compared to a 21% 5-yr avg), investors may get back on-side. However, understanding the cause of the Q3
“volatility” and what can be done to bring close rates back on track will be key to this. Similarly mgt must balance its optimism for a re-acceleration in 2011 with the deceleration evident in H2 1.0.
NH
M&A – still targeting an announcement in Q4
We expect mgt to remain optimistic that an acq’n can be announced in Q4. It took 55 days to announce and close Interwoven, a listed company, and 21 days to complete Zantaz. With 70 days to Christmas the market is probably right to be sceptical a deal can be announced and closed before y/e. However, we think mgt is actively looking still; and an announcement could yet come before y/e.
Valuation: Neutral; 1690p three-pronged price target retained
Sentiment is very poor going into results – in-line could create a bounce. The shares are at 17x our 2011E earnings; 14x excluding the cash on the balance sheet.
BE
Onto the wider market, shall we?
NH
Very exciting out there today
NH
up 1.3 points at 5,704
NH
and most other stuff up
BE
Hang on – why’s Autonomy just spiked?

NH
that will be the bid story
NH
a couple of hours early!
NH
talking of bid stories
NH
a real buzz around in BG today
NH
story around last week of a £14 a share offer from
NH
China’s state-owned gas giant
NH
that’s what we all said
NH
management would want at least £18
NH
however, BG do have a problem
NH
if they are worth £18 a share
NH
why aren’t they trading near it
NH
and what can they do about it?
NH
and the answer to that
NH
was in the Sunday Times
NH
a very good article that said BG could follow the lead of Repsol
NH
and sell a stake in their Brazil pre-salt to get a valuation on it
NH
and perhaps hand back some cash to shareholders
BE
Makes a lot of sense, that.
NH
Last week brought a twist. Shares in the £40 billion company rose on speculation that CNOOC, China’s state-owned gas giant, could be sizing it up. The conventional wisdom is that such a bid is extremely unlikely. Beijng taking control of one of Britain’s business behemoths? Surely not.
But the thinking behind it throws up some interesting questions. BG is focused on three growth areas: the gas-rich coal seams of Australia; the giant oil fields in the deep water off Brazil; and shale gas resources in the American south and Midwest.
Now consider what China has been up to. Two weeks ago Sinopec, CNOOC’s sister company, paid $7.1 billion (£4.4 billion) for a minority stake in Repsol, the Spanish oil group that owns rights to the Brazilian deepwater fields.
Ten days later, CNOOC paid $1 billion for part of a giant shale field in Texas. Last year it signed a 20-year deal to take gas from BG’s coal-seam gas project in Australia. Maybe the rumour-mongers have a point.
NH
It is no secret that the world’s most populous nation is desperate to get its hands on oil. The £50 billion that BG would fetch is too rich for just about anyone — except the Chinese government.
The trick is for BG’s chief executive, Frank Chapman, to close the valuation gap between the price at which bankers think he would be willing to sell — call it £18 a share — and its current trading price of £11.67.
He may have trouble doing that by simply staying the course. If BG meets his rosiest projections, in a decade the company will be producing 1.6m barrels of oil and gas a day — up from an average 644,000 last year.
Making that leap depends on the tricky business of exploiting its vast resources deep under the ocean and in tight geological formations on land. BP has demonstrated the perils that await. Unsurprisingly, investors are nervous.
NH
One option suggested by analysts at HSBC would be to reduce risk, and costs, by selling a minority stake in BG’s Brazilian arm to, say, the Chinese. A 40% stake would, on the Repsol multiple, yield $15 billion — half of which could go back to investors through a special dividend.
That would certainly give a bump to BG’s shares. As Chapman knows well, the best defence is a high share price.
NH
good piece i thought that
NH
wouldn’t mind seeing that HSBC report at some point
BE
Will dig it out. Usual place when I do.
BG Group (BG:LSE): Last: 3,017, up 1 (+158.43%), High: 3,017, Low: 1,158, Volume: 1.47m
NH
interesting situation developing there
NH
are clearly targeting the areas BG are involved in
NH
but if they won’t write the ticket for Potash
NH
will the Chinese govt write the cheque for BG?
NH
the rable are still interested in the foreclosure scandal
NH
and who might be exposed over here
NH
the name HSBC springs up every time
BE
(Seniormuppet et al: sorry – data snafu. Don’t blame us. We just press the buttons, we don’t make the machines.)
NH
(BG is up 16.5p at £11.84)
BE
So – HSBC – what about it?
NH
well, there’s a theory doing the rounds
NH
that they pulled out of the Nedbank deal
NH
not because it was the previous CEO’s deal
NH
but because another blow-up is looming at household
NH
this has been doing the rounds today
NH
LOTS OF NEGATIVE WEEKEND PRESS REGARDING HSBC AND WHY THEY PULLED OUT OF THE NEDBANK DEAL AT THE LAST HOUR, SPECULATION THAT THEY WERE WORRIED BY THE STAN FUND RAISING TOOK CENTRE STAGE BUT ANOTHER THEORY COULD BE THAT THE PROBLEMS AT HOUSEHOLD FINANCIAL(HSBC’s US PROBLEM CHILD) COULD REAR THERE UGLY HEAD AGAIN DUE TO THE FORECLOSURE CRISIS THAT IS STARTING TO ATTRACT HUGE INTEREST FOR THE US. BANKS.
HSBC Holdings PLC (HSBA:LSE): Last: 654.50, up 1.2 (+0.18%), High: 657.80, Low: 652.00, Volume: 8.48m
BE
I thought Household was effectively neutralised.
NH
it might rise from the dead
BE
And hasn’t StanChart categorically denied it’s interested in Nedbank?
NH
but there were some interesting comments from the outgoing Barclays CEO in the paper today
NH
he made some pretty big hints that they liked Africa
NH
made some staggering claims
NH
that ABN would have been a good deal for them
NH
because they would have handled things differently
NH
Bruce Packard has a few thoughts on this
NH
John Varley, outgoing Chief Exec is interviewed in the FT this morning. Comments on Barclays losing out on buying ABN to the RBS led consortium: “There were a portfolio of businesses here, some of which were good and some were not.” Barclays Chief Exec also says there was never any question of trying to buy the whole of Lehman Brothers before it went into bankruptcy without support from the US Government. Probably the most interesting comments are about BIS III, where he praises the substance and timetable of the proposals
NH
. Barclays have previously suggested that BIS III might raise RWA by around a third from £390bn. Also comments on future opportunities in Africa, where Barclays owns Absa (8% of PBT) “If you look at the collective gross domestic product of Africa, it’s bigger than Russia or Brazil. If you look at the growth rates in African GDP, they are high by the standards of the world. I like that option on the future – that’s a very good thing for us to have developed.”
NH
Interesting comments, in light of the exclusive talks for HSBC to buy Nedbank expiring without agreement. Our recommendation on BARC is HOLD, although shares have not recovered since we upgraded from Sell in May when the shares were 288p.
NH
So Barclays for Nedbank
NH
not the sort of thing Diamond Bob likes buying
NH
not nearly whizzty enough
BE
Anyway, Canaccord reckons there’s no reason to panic.
NH
(DLC – it contradicts Sorkin and Paulson. obviously Varley’s memory is going)
BE
There are ongoing reports that banks in the US are struggling to foreclose on mortgages due to ‘low quality’/inadequate documentation (aka ‘Foreclosuregate’) particularly in the context of the securitisation process. Many of the large US banks have now halted foreclosures across 40-50 states. BAC/WFC/JPM down 5%/5%/4% respectively on Friday versus flat S&P. (HSBA down 1.4%).
BE
In our view, in a worst case scenario, this issue might impact HSBC by US$2.5-5.0 billion pre tax – equivalent to
1-2% of market cap. Conclusion: Any near term underperformance for HSBC is likely to be a buying opportunity.
BE
Key features
Two possibilities:
i) At best the costs for US mortgage providers will rise significantly as the banks get increased legal assistance to process paperwork. On some estimates, it can cost US$15,000 to prove title on a mortgage.
BE
ii) There is also a remote possibility that the banks may not be able to prove they own the mortgages due to the complexity of the securitisation process and since the title has changed several times – this could lead to significant losses for the banks since they would be unable to recover the collateral following a foreclosure. Scenario probability <5% in our view.
BE
There is also some risk that the investment banks could be sued since they sold MBS (Mortgage Backed Securities) for which they, in some cases, may have demonstrably known the paperwork had not been processed adequately.
BE
• HSBC is the most obviously affected UK bank, but US mortgages are only 9% of HSBC’s loans, at US$81 billion, implying limited exposure to this issue. We would estimate the maximum likely loss at 3-6% of mortgages, US$2.5-5.0 billion equivalent to 1.0-2.0% of market cap.
BE
Conclusion: Any near term sell off for HSBC on this issue most likely represents a buying opportunity.
NH
In our view, in a worst case scenario, this issue might impact HSBC by US$2.5-5.0 billion pre tax
NH
so that’s small in terms of the market cap
NH
but would still be a nasty hit, no?
BE
To sentiment at very least.
BE
As you say, investors believe Household’s problems are in the rear view mirror.
NH
and for $2.5bn to rise from the grave
NH
not exactly a pleasant surprise is it?
NH
are we bored with banks yet?
BE
I need to do a lot more reading about foreclosuregate, so for the moment, yes.
NH
let’s have a look at the miners
Antofagasta PLC (ANTO:LSE): Last: 1,275, down 32 (-2.45%), High: 1,294, Low: 1,257, Volume: 848.33k
Lonmin PLC (LMI:LSE): Last: 1,789, down 42 (-2.29%), High: 1,804, Low: 1,764, Volume: 229.21k
Xstrata Plc (XTA:LSE): Last: 1,284, down 27.5 (-2.10%), High: 1,289, Low: 1,271, Volume: 3.49m
Vedanta Resources PLC (VED:LSE): Last: 2,238, down 50 (-2.19%), High: 2,269, Low: 2,195, Volume: 493.86k
Rio Tinto PLC (RIO:LSE): Last: 4,062, down 81 (-1.96%), High: 4,099, Low: 4,029, Volume: 1.87m
NH
been hit by the dollar?
BE
Partly, judging by the overnight trade.
BE
Though there’s also a negative note knocking about from Andrew Keen at HSBC.
BE
He thinks copper’s looking a bit squeezy.
NH
at the LME dinner last week
NH
the massive consensus was buy copper
NH
so perhaps a contrarian bet is not a bad one
BE
That’s the note, basically.
BE
Though he explains it with a bit more detail.
BE
The market loves copper, but it is
increasingly a momentum trade and the
upside is compressing
BE
When it feels this consensus, isn’t it time to
switch?
BE
In the short run copper looks as if it could be headed for a
squeeze, and we don’t debate that the market has plenty of
positive momentum. We agree the market looks relatively
tight and have raised our 2011 forecasts. But the problem
from an investment viewpoint is that it is a consensus trade
(LME week confirmed that everybody loves copper) and we
would argue that copper’s good prospects are already in the
price of both the metal and the equities.
BE
We identify three downside risks to copper: demand
destruction at USD4/lb; disruption rates that could already
be double-counted in conservative production estimates; and
that the starting balance in the copper market might not be
the huge deficit that consensus appears to believe. In our
view the question on copper exposure is when to sell it, not
whether it’s worth chasing the end of momentum and we are
downgrading XTA and ANTO on valuation grounds from
Neutral (V) to Underweight (V).
BE
On the other hand, we see both underlying value and upside
risk in aluminium and we have Overweight (V) ratings on
high-exposure European aluminium names (NHY and RIO,
a constituent of the Europe Super Ten portfolio). Granted,
there is still an excess of inventory in the market, but LME
stocks have fallen further in the past 12 months than copper
has. Aluminium is also vulnerable to genuine energy
efficiency efforts in China and industry margins remain
below their cyclical norm.
NH
although if the dollar weakens
NH
I would not want to be short of that trade
NH
sticking with the miners for a moment
NH
interesting note out on Vedanta
NH
making the case for a break up
NH
PRICE: £22.88 | UK | MINING, METALS | VED.L | VED LN
With Vedanta’s listed subsidiaries trading at a value similar to the total sum of the parts valuation, resulting in minimal value attributed to unlisted assets, an IPO of unlisted subsidiaries has previously been flagged as a mechanism through which investors would look more carefully at the SOTP. KCM looks the most likely IPO candidate at this stage, having previously been touted as a listing candidate in 2011. Under such a scenario Sterlite, Sesa Goa, Cairn India and KCM would all be listed with only the energy and aluminium businesses not directly trading. Crucially, debt concerns would be further eased with deleveraging at the group level (we estimate FY2011 net debt of $10.4bn post Cairn India). On MtM PEs of 7.3x FY2011 and 3.6x FY2012 (ex. Cairn) we maintain our BUY.
BE
(@sir incompetent: was that slow death in any way price sensitive? I don’t think it was.)
NH
KCM IPO proceeds to alleviate VED group debt burden: Post the Cairn India acquisition we estimate FY2011 group consolidated net debt of $10.4bn, at the company’s point of maximum leverage, corresponding to net debt / EBITDA of c.2.0x (vs. covenant of 2.75x). While deleveraging in 2012FY and beyond will keep the company comfortably within covenants, proceeds from a KCM IPO would go some way towards easing debt concerns. On an attributable basis we estimate VED net debt at $12.3bn and thus IPO proceeds would compound the deleveraging story at group level.
Sesa Goa H1 FY2011 results later today: We note that Sesa Goa, Vedanta’s 57.4% directly held iron ore business, is reporting later today.
BE
And who had 11:31am in the sweepstake?
BE
11.31am being the time that a commenter would mention BreakingViewsGate.
BE
For those who haven’t seen the story ……….
BE
Oct 18 (Reuters) – A columnist at Reuters Breakingviews has resigned after multiple breaches of the Thomson Reuters TRI.N (TRI.TO) code of conduct on share dealing, and cases involving other commentators are being investigated.
BE
“While we have no evidence the journalist was abusing his position for financial gain, we take such breaches extremely seriously and that journalist resigned with immediate effect during our investigation,” said Reuters Editor-in-Chief David Schlesinger in a note to staff on Monday.
BE
Schlesinger added that several other cases had come to light as a result of questioning Reuters Breakingviews staff where disclosures to readers or managers could or should have been made.
The investigations continue and none of the journalists involved have been named.
BE
Schlesinger said the columnist wrote commentary about companies in which he had a financial interest and made trades shortly afterwards.
NH
he bought shares AFTER he wrote
NH
made a guest appearance on ML once
NH
and he was also the boss of Paul Murphy once upon a time
Former FT Alphaville editor and founder of the site. Now in charge of something called FT Tilt.
NH
here are the refiles Reuters has been forced to put out today
NH
18/10/2010 10:09:16 RM BREAKINGVIEWS-DIAGEO/ REFILE-BREAKINGVIEWS-Diageo offers bond-like solidity
18/10/2010 10:08:55 RM BREAKINGVIEWS-UNILEVER/ REFILE-BREAKINGVIEWS-Unilever’s shocking idea
customers first
18/10/2010 10:08:39 RM BREAKINGVIEWS-UNILEVER/ REFILE-BREAKINGVIEWS-Unilever scrubs up rather well
18/10/2010 10:08:19 RM BREAKINGVIEWS-NORTHUMBRIAN/ REFILE-BREAKINGVIEWS-UK water could disappear beneath the waves
18/10/2010 10:08:04 RM BREAKINGVIEWS-BP/PAIN REFILE-BREAKINGVIEWS-Time for BP to share the pain
18/10/2010 10:07:44 RM BREAKINGVIEWS-BP/LIFE REFILE-BREAKINGVIEWS–More than the dividend now at stake for BP
18/10/2010 10:07:28 RM BREAKINGVIEWS-GOVERNANCE/ REFILE-BREAKINGVIEWS-UK governance code fails at BP, Prudential
18/10/2010 10:07:04 RM BREAKINGVIEWS-BP/BLAIR REFILE-BREAKINGVIEWS-Tony Blair for BP chair
18/10/2010 10:06:55 RM BREAKINGVIEWS-M&S/ REFILE-BREAKINGVIEWS-Good Marks for M&S, but not good enough
18/10/2010 10:06:51 RM BREAKINGVIEWS-NATIONALGRID/ REFILE-BREAKINGVIEWS-National Grid catches market off-guard
18/10/2010 10:06:22 RM BREAKINGVIEWS-BP/ REFILE-BREAKINGVIEWS-BP’s board clean-up has far to go
18/10/2010 10:06:18 RM BREAKINGVIEWS-BHP/ REFILE-BREAKINGVIEWS-The last (iron) straw for BHP/Rio link-up
18/10/2010 10:06:14 RM BREAKINGVIEWS-RIO/BHP REFILE-BREAKINGVIEWS-Rio and BHP steel themselves to abandon JV
18/10/2010 10:06:10 RM BREAKINGVIEWS-TESCO/ REFILE-BREAKINGVIEWS-No limits in sight for Tesco
BE
And I guess all the syndications will have to be updated in a similar way.
NH
the Telegraph had moved to do that
NH
I need to finish at midday sharp today
NH
and we still have loads of small cap oil to look at
NH
a couple of deals to reflect on
BE
Bluebay’s the biggest, I guess.
BE
At least by market cap, if not by interest.
Bluebay Asset Management Public Limited Company (BBAY:LSE): Last: 487.30, up 111.6 (+29.70%), High: 495.00, Low: 487.00, Volume: 2.95m
NH
management have signed up
NH
and they have pledged the stock
NH
and won’t sell even if there is a higher off
NH
485p a share plus a divvy
NH
around 18 times next years earnings
NH
although it has started something of a guessing game
NH
as to who might be next
BE
Bluebay’s quite specialist.
BE
Fixed income. Emerging markets.
BE
How much read-across is there?
NH
but analysts are still excited
NH
Aberdeen (ADD TP181p): We believe that on just 10.6x one year forward earnings,
the business would be attractive to a financial conglomerate looking to add a well
diversified, global asset manager, both from a value perspective and from a strategic fit perspective (a “ready made” global asset manager). Whilst we acknowledge that many large financial conglomerates no longer have the spare capital that was once at their disposal, in the long term we do not see this as a significant obstacle. Moreover, we do not believe that Mitsubishi would regard its c.17% holding as the end game – we believe they are much more likely long term buyers of the remaining shares.
NH
Tullett (BUY TP523p): Tullett received a bid approach earlier this year. Given the
discount valuation and global market leading position we see the possibility that not
only could a bid resurface, but it could well end up being contested. Terry Smith has
repeatedly said he would sell the business if an offer that valued the business fairly was made. We believe the most likely bidder would be an exchange looking to share IT costs, benefit from the IDB space becoming exchange like in its nature, the potential to deepen their client relationships by offering multiple products and the huge valuation differential between Tullett and ICE and the CME.
NH
moneysupermarket.com (BUY TP95p): Now that the vesting period has ended, Nixon is able to sell 100% of his c.52% stake. We believe the business would be of interest to private equity due to i) its strong cash flow generation, ii) current ungeared structure and iii) past interest in the sector (e.g. Apax’s takeover of bankrate.com in 2009, Ontario’s initial interest in MONY in 2008). We also note that Google has toyed with the idea of moving into price comparison (beta tests of credit cards in 2010 and mortgages in 2008). We also note that they have in the past acquired market leaders when moving
NH
as for some comment on BlueBay
NH
KBC think it is being sold on the cheap
NH
BlueBay has announced a recommended offer by Royal Bank of Canada
at 485p per share, valuing the company at £963m, equivalent to 27.1x
historic earnings and 21.7x 2011E EPS. Shareholders will also receive
the proposed 7.5p final dividend.
• The offer price is a 29% premium to Friday’s closing price, though it is
15% below the peak of 568p achieved in June 2007.
• Irrevocable undertakings have been given by the BlueBay directors, in
respect of 20.5% of the issued share capital. Completion is expected by
end December.
NH
• Separately, BlueBay has announced AUM of $40.0bn at 30th September,
a touch ahead of our estimate of $38.5bn. The difference is attributable to
investment performance and FX (+$4.5bn compared with our estimate of
$2.4bn), with net flows of $1.2bn in the quarter being $0.6bn lower than
we had expected. Performance fees are estimated at £13.7m (JPMC:
£10.6m for H1).
• The sale of BlueBay to RBC is a surprise, and brings to a close a
relatively short but eventful stock market listing. While there is little
direct read-across to other stocks (though speculation in the smaller,
cash-rich companies is possible), in our view the advent of M&A after
the recent market rally (e.g. UK All-share +16% since end Q2) will offer
support to the sector.
NH
so I guess one could say
NH
although it is well above the trough
NH
also short of the peak
NH
(Fitz – happy with charts. I will respond to the LR request soon)
BE
Breaking Beazley news.
NH
The Board of Hardy (LSE: HDU), the specialist Lloyd’s insurer, notes the announcement made today by Beazley plc (“Beazley”). The Company confirms that it received an unsolicited letter on 6th October 2010 from Beazley setting out details of an indicative proposal to acquire the entire issued and to be issued share capital of Hardy at 300p per share (the “Proposal”). The Proposal is subject to a number of pre-conditions, including due diligence and the unanimous recommendation of the Board of Hardy.
NH
The indicative, non-binding Proposal substantially undervalues the Company and does not reflect its:
· strong historic underwriting track record;
· clearly stated and successful growth strategy of prudent diversification and the pursuit of selective opportunities that lever its niche skills in complementary sectors and geographies;
· focus on attractive short tail niche lines of business;
· high quality underwriting teams and management, recently complemented by the opening of the new Singapore office; and
· prudent reserving policy.
NH
The Hardy principles of underwriting expertise and prudent reserving, together with successful cycle management have led to a track record of sustained profitability both at Group as well as syndicate level. Hardy’s significant growth over the last few years has been achieved without compromising underwriting standards. Hardy is enhancing its current strategy by actively developing opportunities where the Company already has complementary expertise and through the development of a broader geographical reach including the Asia Pacific region.
The Board views the Proposal as an attempt to acquire the Company opportunistically, when valuations of listed Lloyd’s companies are at a cyclical low and to exploit the impact on Hardy of a series of exceptional international property treaty losses
The Board, having carefully considered the Proposal together with its advisers Rothschild and KBC Peel Hunt, was of the unanimous opinion that it significantly undervalues the Company and consequently had no hesitation in rejecting the Proposal
NH
Not much of an expert on underwriting
NH
most of the people who are
NH
reckon the Beazley will have to increase its offer
Hardy Underwriting Bermuda Ltd (HDU:LSE): Last: 289.00, up 45 (+18.44%), High: 295.00, Low: 285.00, Volume: 164.00k
Beazley Plc (BEZ:LSE): Last: 119.90, up 5.4 (+4.72%), High: 121.40, Low: 116.10, Volume: 484.45k
NH
a Happy Mondays tribute
BE
Madforit Underwriting.
NH
looks a bit cheeky I reckon
NH
I had a good note from Shore Cap on this
NH
BEAZLEY^ (BEZ, Hold at 115p) – bid for Hardy^ (HDU, Buy at 244p) – following on from the Apollo/Brit move and RSA’s move for the non-life parts of Aviva, we have the latest slice of corporate activity with an attempted bid by Beazley to buy Hardy. An approach of 300p in cash was made on the 6th October by Beazley, which was promptly rejected by Hardy (on Mon 11th October). The bid, to be met from Beazley’s internal resources, equated to 1.2x NTAV at end of June 2010. By this public declaration Beazley is clearly attempting a ‘Board by-pass’ and appealing directly to shareholders
NH
To us, for the approach to succeed Beazley will have to significantly increase its offer. Hardy’s current rating reflects the impact of a couple of unlucky hits in Australia, opposed to some fundamental issue with its model or underwriting portfolio. As we have argued before, the current rating of Hardy overlooks the conservatism of its reserving philosophy and its accounting (leading to an understated NTAV), as well as its underwriting track record. We reiterate our BUY recommendation on Hardy’ whilst reiterating our HOLD recommendation on Beazley. Further afield, continuing the corporate theme, we continue to view both Chaucer^ (CHU, Buy at 49p) and Omega^ (OIH, Buy at 97p) as vulnerable to interest from corporate predators.
NH
and something from KBC
NH
Beazley has made a cheeky approach to acquire Hardy this morning that contains little detail on why the acquisition would make sense and what it would add to shareholders. The indicative proposal is pitched at 300p per share representing 1.17x NTA (257p) as at 30 June and 1.09x our estimate of year end NTA (276p).
Why has this occurred? The premium valuation historically commanded by Hardy has come under pressure following an unusually active H1-10 for international Catastrophe’s. Hardy was hit harder than its peers due to its atypical CAT exposure which is 70% International and 30% US. This does not mean that Hardy is not the quality business that we previously thought. The nature of insurance is that losses will be encountered from time to time. Hardy’s CAT account was profitable in 07, 08 (despite Ike & Gustav) and 09 while the business has never reported an underwriting loss since it was founded back in 1974. H1-10 has been its turn to pick up some losses. Moreover, Hardy is non-correlated to the rest of the Lloyds sector due to the shape of its CAT account and therein lies the greatest investment attraction for shareholders. We are confident that a mean reversion will occur as the Group returns to its trajectory of delivery.
NH
Why has Beazley made this approach? Beazley’s statement provides absolutely no detail on why it makes sense for it to acquire Hardy and indeed I don’t believe that this is a situation of 2+2 makes 5; I think it may well be 3! The implication has to be that the only logic is that it sees the opportunity to pick a quality asset up on the cheap and on this basis it makes no sense for shareholders to accept such an offer. The losses which Hardy experienced in H1 are simply a reflection of an unusually active period of international Catastrophe activity that is not likely to occur on an ongoing basis and certainly not a reflection of any inadequacy in terms of underwriting. This being the case we believe that Hardy will quickly regain its premium rating.
My thoughts: I view this as a cheeky offer that has been predicated on buying a quality asset on the cheap. Given that the underwriting standards that have produced an unbroken track record of underwriting profitability dating back to 1974 remain intact it doesn’t seem appropriate to consider an offer for the business after it has witnessed a bump in the road created by a exceptional period for international CAT activity that is highly unlikely to recur. If shareholders are keen to consider consolidation opportunities and given the high probability of a mean reversion in terms of underwriting performance it would seem to make sense to me to wait until Hardy has regained its premium rating.
NH
Time for Dinner Party Live
NH
we are on to housebuilders
BE
Ok – this is on the obviously nonsense Rightmove survey.
BE
The average house price is now £236,849.
BE
Though that’s asking prices.
NH
so Halifax says house prices down 3%
BE
Well, Rightmove represents the “assumed 10-15% discount” sellers now expect to take.
BE
So it is, quite simply, a bobbins survey.
BE
Here’s Howard Archer to say the same, albeit in rather more measured language.
NH
Tongest – Goldman Sachs?)
BE
Rightmove reported that asking prices for houses rose by an incredibly optimistic 3.1% in the month to mid-October. This followed declines in each of the previous three months, including a drop of 1.1% in September. Despite the sharp monthly rise in October, the year-on-year increase in asking prices only rose back up to 2.9% after dipping to 2.6% in September from 4.3% in August and 6.0% in April.
BE
Greater London saw asking prices rise by an even more optimistic looking 5.0% month-on-month in October, although the year-on-year increase actually moderated to 0.6% from 2.1% in September. While London prices have often been supported by a lack of stock, Rightmove noted that this time around there is a 34% year-on-year increase to 4,624 in the number of properties coming on to the market.
On the face of it the 3.1% rise in asking prices for houses in October seems completely at odds with the plethora of data and survey evidence indicating that the housing market is on its knees. And, of course, it is. But two points must be made:
1) The data are not seasonally-adjusted and asking prices tend to rise markedly in October as the autumn is normally a buoyant time for the housing market
2) These are vendors’ asking prices for house prices and not the price finally achieved.
BE
Does this spike up in asking prices for houses in October reported by Rightmove fundamentally change our view that house prices will trend down over the final months of 2010 and during 2011 to lose around 10% of their value?
BE
In a word – No. There can be little doubt that many sellers are “trying it on” and deliberately asking inflated prices, knowing that they will be knocked down by potential buyers who have the upper hand given the current weak state of the housing market. These sellers are likely hoping that they will get a price nearer to what they really want if they ask an inflated price to begin with. The danger with this, of course, is that they risk getting little, if any, interest from buyers in their houses.
Admittedly, some vendors (particularly those that are not under any form of pressure to sell) may hold out for some time in accepting a significantly lower price than they are asking for. And some vendors may not be prepared to accept the prices they are being offered and take their house back off the market.
BE
In fact, other elements of the Rightmove survey reinforce our view that house prices are headed lower. In particular, Rightmove reported that the average unsold stock per surveyor was still up at 78 in September (which was only marginally below the record high of 79 seen in August and July). Furthermore, Rightmove revealed that many agents reported “buyer activity failing to pick up after the summer break”. In addition, Rightmove highlighted “deteriorating mortgage availability”.
We expect house prices to trend down relatively gradually over the final months of 2010 and in 2011 to lose around 10% in value. There is however likely to be significant volatility around this gradual overall downward trend. High (and likely to rise) unemployment, muted wage growth, an increasing fiscal squeeze, low consumer confidence, difficulties in getting a mortgage, a housing supply/demand balance currently firmly in favour of buyers and a house price/earnings ratio above long-term norms are a poor combination of factors for house prices. Low interest rates and the current stamp duty holiday for first-time buyers on all properties costing up to £250,000 only partially offset these adverse factors.
NH
(Tongster – seriously I have heard rumours that HSBC would like to build out their corporate broking business in the UK. So I reckon it might be them)
BE
(I’ve heard the same rumours, as it happens.)
NH
I am not sure it is up because of the world’s most ludicrous house price survey
Barratt Developments PLC (BDEV:LSE): Last: 89.95, up 2.95 (+3.39%), High: 90.05, Low: 85.75, Volume: 4.34m
NH
i reckon it has more to do with some director share buying on Friday
NH
Barratt announced that Finance Director David Thomas acquired 30,000
shares on Friday, taking advantage of the fact that the stock is trading on a
60% discount to tangible NAV. Despite the fact that market conditions
remain uncertain, we believe that investors willing to take a medium term
view should see good returns as the NAV discount narrows over time. We
reiterate our Buy recommendation and 153p target price
NH
Rationale for discount has weakened. The rationale behind that huge discount has
weakened in our view;
Firstly, the group has significantly improved its balance sheet over the past 18 months.
Gearing at the year-end on a net tangible basis was 18%, down from 89% a year earlier
and we would expect it to be maintained around this level in 2011. There are therefore
no issues from a debt perspective.
Secondly, it is well known that Barratt took the lowest write-downs of all during the last
downturn, and so it is natural to read across that the business will be the first to see
write-downs should prices start to fall again. This is certainly true, but with net margins
at the group now running around 6%, the company could absorb at least that much
deflation before write-downs occur again.
NH
Recommendation. On that basis, despite the fact that market conditions remain
uncertain, a 60% NAV discount looks overly cautious to us. For investors willing to take
a medium term, view there should be good returns to have as that discount narrows. We
therefore maintain our Buy recommendation and 153p target price.
NH
A bit bullish for my tastes
NH
even more unbelievable than the REuters thing taking 30 minutes to surface
NH
is the fact that no one has mentioned it
The next supermajor, potentially sitting on 60bn barrels of oil in Kurdistan. Loved by muppets across the globe.
Gulf Keystone Petroleum Ltd (GKP:LSE): Last: 155.00, up 11.5 (+8.01%), High: 156.00, Low: 148.00, Volume: 5.44m
BE
They’re up. They have no reason to scream at us for being in league with the derampers.
NH
they do seem to get through the cash rather sharpish
NH
although who can blame them for raising money
NH
their share price has doubled in three month
BE
(One-fifty-five pence! Incredible.)
NH
worth more than £1bn now
BE
So the Iraq Supermajor’s raised £109.24m at 140p
BE
It’s a precise company. A grasp of miniscule detail is essential.
BE
Anyway, that’s basically no discount to Friday.
NH
Right I have got a bit of broker comment on this
NH
because I don’t want to spend another afternoon looking at dreary emails
NH
telling me that I should be sacked for trying to bring down a great British success story
NH
so we kick off with the negative
NH
GKP has completed its third fund-raising of the year and
takes the total new money raised during 2010 to c$670m. We find the size
and timing of this latest raise hard to fathom and believe the company is
taking full advantage of a share price that has seen an extraordinary
recovery over the past three months. We would have preferred more
appraisal work to have been completed before this raise but for the time
being we leave our TP and Recommendation unchanged
NH
GKP announced over the weekend that it has raised £109m at 140p/share, a small 2% discount to Friday’s close. The cash will be used to hire a third rig in Kurdistan, with the immediate focus being the appraisal of the Shaikan oil discovery. The delayed Shaikan-2 and 4 wells will now be drilled as well as three new wells (5, 6 and 7). Exploration on other blocks will also be accelerated. There remains uncertainty over the size of the find with the group still quoting a P90/P10 reserves range of 1.9 to 7.4 barrels of oil in place with a mean P50 of 4.2bn barrels. Moreover there is no indication yet of recovery factors – this could be anything from low teens to 50% or better. It sounds like it won’t be any time soon that this band will be narrowed as appraisal drilling will now not complete until end H1 2012. Given the remaining uncertainties I’d put my money elsewhere.
NH
and here is the positive
NH
Maximising value
The fundraising materially strengthens Gulf Keystone’s balance sheet, enabling the company to accelerate activity across its portfolio, while also maintaining the financial flexibility to pursue value-added, bolt-on acquisitions in-country, should they arise. The addition of a third operated deep rig for Shaikan and two fully funded exploration wells on the non-operated blocks should maintain the pace of news flow over the coming 12 months. Ultimately, we expect Gulf Keystone to fall prey to a larger rival and today’s fundraising should ensure that shareholder value is maximised before exports restart and Kurdistan is opened up. To this end, we view it as a key step forward.
BE
Mirabaud are the shop broker, aren’t they?
BE
And they reckon, to paraphrase, that it’s all preparation for a trade auction.
NH
(dai versify – your banned. don’t ever come back. unless that was sarcasm)
Warning to rude and abusive commenters – your ability to comment will be terminated immediately and permanently, without warning. Henceforth, FTAlphaville has instituted a One Strike and You Are Out policy. We’ve had enough. We are going to clean up these pixels once and for all.
NH
Previously we mused that Gulf Keystone would return to the market and
raise additional funds especially if they contracted for a third rig. In our
view this is a very positive development for the company. Drilling
operations in the region are difficult and tend to get expensive. This fund
raise reduces the fiscal concern (if any) that their might have been for the
company to fund Shaikan appraisal work and further exploration
NH
no emails, letters from GKP’ers
NH
take your complaints to the analysts not me
BE
Meanwhile, while in Iraq
NH
(dai versify – you have been reprieved)
BE
Someone — I forget who, sorry – - was asking about Heritage
Heritage Oil Plc (HOIL:LSE): Last: 342.90, down 5 (-1.44%), High: 347.60, Low: 340.50, Volume: 248.19k
BE
Genel’s sold down stakes in its Kurdistan fields to South Korea
BE
$175m for a collection of piecemeal bits and bobs.
BE
Tawke field (5%), Dohuk exploration licence (5%) and Miran licence (10%)
NH
so not much read across then
NH
we need to reconsider the GKP valuation
NH
£1bn looks way over the top
BE
Anyway, here’s Evolution trying to get its head around the potential benchmark.
BE
At this stage there is no breakdown of the value per
licence. However, if we pro rata the US$175m across the expected
recoverable reserves per licence then this would imply a value of U$70-
80m for the 10% in Miran, and correlates with the risked value we have in
our model for Heritage’s 56% stake in Miran (post government back in
rights). However, unless Heritage pre-empts on Miran we are unlikely to
get a separate value for the Miran component of the deal.
BE
DETAILS – Genel Enerji currently holds a 40% stake in the Dohuk licence
and 25% each in the Miran licence and Tawke field. The Kurdish
government gives separate approval for each licence transaction.
BE
VALUATION AND RECOMMENDATION –Cash on the balance sheet and
Russian producing asset give a Core NAV of 228p/share. Our Core +
Risked upside including Miran West, East, Malta and Pakistan is
692p/share, of which Miran West (excluding the deeper Jurassic/Triassic
targets which could double resource estimates) is risked at 97p/share.
BE
That’s from Richard Griffith.
NH
interesting note out on Nat Grid
NH
saying it should sell its US business
NH
and with a new finance director in place
NH
I think we could see some action
National Grid PLC (NG.:LSE): Last: 568.00, down 1.5 (-0.26%), High: 574.00, Low: 566.00, Volume: 4.21m
NH
US restructuring is a must
At current share price, National Grid trades at a 13% premium to its US rate base which is both at a discount to peers and implies little change from the status quo. We believe that there is significant shareholder pressure to prove the value of the US business with the current status quo not being a sustainable position. There are several restructuring options available including tariff renegotiation and asset sales.
Upside in all restructuring scenarios
Successful tariff re-negotiation in our view offers over 15% share price upside and adds 10% growth to earnings from FY 2010 levels. In the event that National Grid is not successful in achieving an adequate US return, divestments should not be ruled out. Recent asset sales (Iberdrola, E.ON) suggest multiples that could offer up to 22% share price upside. Assuming that 100% of the US business is sold at 150% premium to rate base, followed by a buy back of £.8bn (at the current share price) could give 33% upside.
NH
Attractive income at compelling value
At 8.4x March 2012E EV EBITDA, National Grid trades at a 9% discount to its regulated peers, with broadly the same growth. Furthermore, the company yields 6.8%, a 33% premium to its peers. Along with International Power, Enel, EDP and EDF, National Grid is a Pan European top pick.
Valuation: Maintain our Buy stance, increasing our PT to 615p
We upgrade our price target by 50p/share to 615p, maintaining our Buy recommendation. Our valuation is sum of the parts derive
NH
the rumour is mutating
NH
now the talk is of a Chinese bidder
NH
LVMH is wrong apparently
BE
Damn expensive, Hermes. Definitely dilutive for LVMH.
NH
appeals more to the strategic buy
NH
and we didn’t even have time to mention gout
Hikma Pharmaceuticals Plc (HIK:LSE): Last: 733.00, down 8.5 (-1.15%), High: 741.00, Low: 722.50, Volume: 119.11k
BE
Something of a climbdown
BE
Though they dress it up rather differently
BE
Here’s the summary from Numis, which was of course preeminent in bringing the issue to the market’s attention.
BE
Hikma this morning announced that it has “resolved” its dispute with URL
Pharmaceuticals to both “parties’ mutual satisfaction”. Hikma’s US oral generics
division, West-ward, has now discontinued its sales of colchicine tablets for gout.
We have reduced our FY’10e estimates to reflect Hikma’s early withdrawal of
colchicine, with group sales falling from $748m to $736m, PBT down from $138m to
$133m. We retain our sell recommendation on the basis of punchy valuation
combined with the risk of H2’10 disappointments from the key Branded division.
BE
URL had been pursuing Hikma for “loss of sales” in the US District Courts in California
and New Jersey, where Hikma lost a Motion for Summary Judgement two weeks ago,
ie. Hikma attempted to persuade the judge that it had no case to answer. However, the
judge denied this, deciding that URL’s claim should go to trial on the basis of the
evidence presented. IMS Health prescription data suggests that Hikma sold as much as
$30-35m oral colchicine in H1’10, although we understand from the company that this
may have been as little as $15-20m, at exceptionally high margins (where prescription
prices rose from $4 to $70 over a matter of weeks).
BE
Given the potential size of URL’s “loss of sales” claim from H1’09 through H2’10, we
assume that monies changed hands, from Hikma to URL, to make this problem go
away. The reputational risk to Hikma’s important Middle East & North Africa (MENA)
franchise would have made a high profile US trial an unwanted distraction. Hikma
explains that the terms of the resolution remain confidential but are not material enough
to require any detailed disclosure to the market.
BE
Interestingly, Hikma announces that it has also filed its own 505(b)2 application to sell
colchicine, anticipating approval by Q3’11. When we spoke with the FDA’s Unapproved
Drugs Coordinator, they doubted whether a second drug would be able to gain an
approval in a space where URL has already secured rights over acute gout, chronic
gout, and familial Mediterranean fever (FMF). Possibly, Hikma is seeking a small fourth
indication, as a way for them to close this issue gracefully.
BE
Our FY’11e sales estimates are now 2% below consensus, with PBT 10% lower, partly
as a result of lower contribution from Generics, particularly lower profitability with the
removal of high margin colchicine. However, more importantly for the short term, we
remain concerned that the group’s Branded and Injectables businesses are expected to
grow +25% yoy in H2’10. This looks challenging.
BE
It seems a remarkable number of our posters have gout.
BE
I hope correlation does not, in this case, equal causation.
BE
“Alphaville gives you gout” is unlikely to win us another Webby.
BE
And, on that note, Neil has run off to lunch so it’s left for me to say …..
BE
Thanks for all your comments this morning.
BE
Join us again, same time tomorrow, for more of the same.
BE
(@JW The Travelzest rumour has been persistent for about six years. Will make some calls and, if there’s anything to say, we’ll update tomorrow.)
BE
Good afternoon, everyone.